Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/2392
Title: Silymarin for Liver Disease
Authors: Abenavoli L.
Milić, Nataša 
Issue Date: 23-Mar-2017
Journal: Liver Pathophysiology: Therapies and Antioxidants
Abstract: © 2017 Elsevier Inc. All rights reserved. Silybum marianum or milk thistle (MT) is the most well-researched plant in the treatment of liver disease. The active complex of MT is a lipophilic extract from the seeds of the plant and is composed of three isomer flavonolignans (silybin, silydianin, and silychristine), collectively known as silymarin. Silybin is the component with the greatest degree of biological activity and makes up 50-70% of silymarin. Silymarin acts as an antioxidant by reducing free radical production and lipid peroxidation. Silymarin has been used to treat alcoholic liver disease, viral hepatitis, and toxin-induced liver diseases, and can be promising in the approach to hepatocellular carcinoma.
URI: https://open.uns.ac.rs/handle/123456789/2392
ISBN: 9780128043219
DOI: 10.1016/B978-0-12-804274-8.00045-X
Appears in Collections:MDF Publikacije/Publications

Show full item record

SCOPUSTM   
Citations

14
checked on Sep 9, 2023

Page view(s)

12
Last Week
7
Last month
0
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.